Skip to main content
. 2012 Oct 17;2012(10):CD004626. doi: 10.1002/14651858.CD004626.pub3
Study Reason for exclusion
EBMTR Insufficient information on baseline characteristics (less than 5 factors without substantial missing data).
Insufficient information on treatment plan, already apparent imbalances between use of TBI in the "planned" or "unplanned" group.
Kim 2009 No separate information on patients receiving either one or two transplants.
Koren 2010 No separate information on patients receiving either one or two transplants.
Lahuerta 2003 No separate information on patients receiving either one or two transplants.
NMSG Insufficient information on baseline characteristics (less than 5 factors).
Insufficient information on treatment plan.
Sonneveld 2007 Non‐myeloablative dosing regimen of melphalan (2 x 70 mg/m²).
Total therapy No RCT.
No contemporary control group.
Of note: integration of novel agents in TT generation >1 is regarded as a critically different treatment approach compared to the set of included RCTs.